Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines. (2019)

First Author: Passmore IJ
Attributed to:  Development, production and testing of novel glycoconjugate pig vaccines funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12917-018-1751-2

PubMed Identifier: 30606265

Publication URI: http://europepmc.org/abstract/MED/30606265

Type: Journal Article/Review

Volume: 15

Parent Publication: BMC veterinary research

Issue: 1

ISSN: 1746-6148